Supplementary Table S3 from Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and Its Expression Associates with Favorable Survival for Stage III Melanoma
posted on 2023-03-31, 18:49authored bySuhendan Ekmekcioglu, Michael A. Davies, Keiji Tanese, Jason Roszik, Myung Shin-Sim, Roland L. Bassett, Denái R. Milton, Scott E. Woodman, Victor G. Prieto, Jeffrey E. Gershenwald, Donald L. Morton, Dave S. Hoon, Elizabeth A. Grimm
This file contains adjuvant treatment distribution in validation set (MDACC) in all patients.
Funding
MD Anderson Cancer Center
NIH
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
The University of Texas, M.D. Anderson Cancer Center Melanoma Moon Shots Program